← All organizations
Highest phase reached
Phase 1
First clinical trial
May 20, 2019Last known activity
Sep 16, 2025
Acquired by Shionogi on Jun 26, 2023
Timeline
2010s
- Jun 1, 2018
Qpex Biopharma, Inc.— Founded
2020s
- Jun 26, 2023
Shionogi— Acquired By
Drugs by trial phase (8 distinct, 10 trials)
Phase 1 (8 own, 0 via acquisition)
Indications
Studied for
Recent trials (17)
- NCT07104162Lead sponsorPhase 1Sep 16, 2025
- NCT07083817Lead sponsorPhase 1Aug 13, 2025
- NCT06547554Lead sponsorPhase 1Sep 4, 2024
- NCT06157242Lead sponsorPhase 1Jun 1, 2024
- NCT06157242Study directorPhase 1Jun 1, 2024
- NCT06079775Lead sponsorPhase 1Jan 20, 2024
- NCT06079775Study directorPhase 1Jan 20, 2024
- NCT05072444Study directorPhase 1Nov 15, 2021
- NCT05072444Lead sponsorPhase 1Nov 15, 2021
- NCT04808414Lead sponsorPhase 1Jun 3, 2021
- NCT04808414Study directorPhase 1Jun 3, 2021
- NCT04578873Study directorPhase 1Apr 13, 2021
- NCT04578873Lead sponsorPhase 1Apr 13, 2021
- NCT04380207Lead sponsorPhase 1Sep 28, 2020
- NCT04380207Study directorPhase 1Sep 28, 2020
Details
- Founded
- San Diego, CA, US Jun 1, 2018
- Last known activity
- Sep 16, 2025